Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.
about
Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical updateTiming and extent of response in colorectal cancer: critical review of current data and implication for future trialsTracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncologyRole and mechanisms of resistance of epidermal growth factor receptor antagonists in the treatment of colorectal cancer.Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.
P2860
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@en
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@nl
type
label
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@en
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@nl
prefLabel
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@en
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@nl
P2093
P2860
P356
P1476
Evidence-based appraisal of th ...... ic colorectal cancer patients.
@en
P2093
Elena Ongaro
Giuseppe Aprile
Laura Ferrari
Mariaelena Casagrande
Stefania Eufemia Lutrino
P2860
P304
P356
10.3748/WJG.V19.I46.8474
P407
P577
2013-12-01T00:00:00Z